Navigation Links
Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 11, 2007 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, will present preclinical data for Talvesta(tm) (talotrexin) for Injection at the American Association for Cancer Research 100th Annual Meeting April 14-18, 2007 in Los Angeles, California.

Abstract No. 2210: "Combining talotrexin (PT-523) with paclitaxel in A549 non-small cell lung cancer (NSCLC) athymic nude mice xenografts" will be presented in a poster session on Monday, April 16, 2007 from 8:00am to 12:00pm PDT, in Poster Section 23, Tumor Biology 15, in the Exhibit Hall. Board No. 8.

About Talvesta(tm) (talotrexin) for Injection

Talvesta(tm) is a novel nonpolyglutamable antifolate drug under development for the treatment of various types of cancers. Talvesta has demonstrated enhanced antitumor activity in a broad spectrum of preclinical studies by targeting the enzyme DHFR to prevent DNA synthesis in tumor cells and inhibit tumor growth. These studies suggest that Talvesta, as compared to methotrexate, enters into cells up to ten times more efficiently and demonstrates 10- to 100-fold more potency in overcoming polyglutamation, a well-established mechanism of antifolate resistance. Talvesta also binds more tightly to its anti-tumor target DHFR, which Hana believes may further inhibit tumor growth. In May 2006, the U.S. Food and Drug Administration granted orphan drug designation for Talvesta in patients with ALL.

About Hana Biosciences, Inc.

Hana Biosciences, Inc. (Nasdaq:HNAB) is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care. The company is committed to creating value by building a world-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner o
'"/>




Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia
2. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
3. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone

Post Your Comments:
(Date:11/23/2009)...-BridgePointMedicalannouncedtodaythatitreceivedEur...eripheralChronicTotalOcclusion(CTO)CrossingSystemc...eStingray®CTORe-EntrySystem.TheBridgePointSys...edtonavigatehighlydiseasedarteriesinpreparationfor..., TheNationalHeart,LungandBloodInstitute(NHLBI)es...
(Date:11/23/2009)...re-FirstCall/-- CumberlandPharmaceuticalsInc. (CPI...astudyevaluatingthesafetyandefficacyofCaldolor( ib...npatients. ,, Statisticalsignificancewasachieve...soverthefirst24hoursoftreatment.Thestudyevaluated6...ringmorethan10percenttotalbodysurfacearea.Otherpar...
(Date:11/23/2009)...--AMDLASERSannouncedthisweekthatitcontinueswithano...restigiousindustry-leaderDr.LarryRosenthalandAesth...vesofttissuediodelaserusedduringallinternationaled...ntists. ,, (Photo: http://www.newscom.com/cgi-b...asurethatIproudlyannounceourpartnership.Softtissue...
Breaking Medicine Technology:BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Forty two of Simceres Generic Drugs Enter Chinas Essential Drug List 13646 1Forty two of Simceres Generic Drugs Enter Chinas Essential Drug List 13646 2New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene Editing Technology 13645 1New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene Editing Technology 13645 2New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene Editing Technology 13645 3No Economic Slowdown for Expanding U S Medical Manufacturer 13644 1No Economic Slowdown for Expanding U S Medical Manufacturer 13644 2
...--(BUSINESS WIRE)--Apr 5, 2007 - MIV Therapeutics ...f next-generation,biocompatible coatings and advan...s and other implantable medical devices, today,ann...confirmed that,merging Biosync Scientific,s certif... acquired, with the Company,s polymer-free drug,de...
...sters Relating to Company Oncology Programs to be ...2007,/PRNewswire-FirstCall/ -- Cytokinetics, Incor...ng non-clinical data will be,presented at the 2007...ncer Research (AACR) to be held from April 14- 18,...d to multiple oncology,programs at Cytokinetics an...
Other Medicine Technology:MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 2MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 3MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7
(Date:11/23/2009)...tedConcordiaDental,oneofthenation,slargestdentalin...unitedconcordia.comwhichprovidesimprovedaccesstoin.... ,, "Thesiteboastsacleandesign,betterorganizat...itorsfindinformationquicklyandeasily,"saidPaulJone...."Fresh,relevantcontent,coupledwithanimprovedeaseo...
(Date:11/23/2009)...ade,M.D.announcesthenewlyenhancedCyberKnifeequipme...fMiami,( www.cyberknifemiami.com ). ,, TheCyb...sedoseofradiationthatkillscancercellswithnoinvasiv...om30minutestoonehour,andisusuallycompletedin1-5tre...intheSoutheasternU.S.,theMiamifacilityhasledtheway...
(Date:11/23/2009)...al and physical health , , MONDAY, Nov. ...as many years off your life as smoking does, a new...pression and anxiety appears to be better for long...to their conclusions after analyzing death records...he four years after the survey, the death rate was...
(Date:11/23/2009)...ovember issue of GIE: Gastrointestinal Endoscopy ...the American Society for Gastrointestinal Endoscop... that Barrett,s esophagus was detected in six perc...reening. Also in this issue, two studies examined ...ce, in the largest single-center experience to dat...
(Date:11/23/2009)...ystem study has found that one out of five Type 2 ...ounds or more overweight. , Researchers reported...etes are obese, and 20.7 percent are morbidly obes...tes, 1 in 3 is morbidly obese. , "The rate of mo...ing at a very alarming rate, and this has substant...
Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Diabetics show alarming increase in morbid obesity 2
...d of protection against bird flu has been studied ...at the University of Rochester. // This involves a...emic of bird flu hits, it would take months to dev...accination. An initial dose of the vaccine is give...
...st advanced nations of the world today, Britain ha...e most 'obese nation in Europe' last week. //In a ... more than one –fourth of the nation's population ...ards improving people's quality of life through go...
...rds today throughout the country are 'Dengue' an...brought on by the bite of an infected// Aedes aeg...olling in several Indian states. Dengue is the m...ning to go out of hand unless a formidable solutio...
...eople have died of dengue fever in the Dominican R... the health authorities announced a drop in the nu...al patients hit by the disease this year is nearly...ojas said a large number of student volunteers wil...
...avels that other factors play a strong role along ...Down's Syndrome.// Many older women who have been ...ound out that they are pregnant often find themsel...us (unborn developing baby) being malformed or men...
...rs at the Launceston General Hospital have develop... According to the director of the LGH Dementia Res...luid from the brain can treat one type of dementia... and women of the age 58-92 years, from the hospit...
Other Medicine News:Health News:Dengue and Chikungunya: The Dirge of a Nation 2Health News:Dengue and Chikungunya: The Dirge of a Nation 3Health News:Dengue and Chikungunya: The Dirge of a Nation 4Health News:Cause of ‘Down Syndrome’ cannot be pinned down to maternal age alo 2
Pefakit TAFI
Pefakit TAFI Calibrator/Control
QuikCoag Control 2
...to address hematology needs in today's changing la..., closed-tube sampling, small sample requirements,... modern hematology lab. New challenges have made f...nt, and simplification of data interpretation nece...
Medicine Products: